Mark Wilterding | Vice President, Investor Relations |
Mike Mussallem | Chairman and Chief Executive Officer |
Scott Ullem | Chief Financial Officer |
Bob Hopkins | Bank of America |
David Lewis | Morgan Stanley |
Larry Biegelsen | Wells Fargo |
Vijay Kumar | Evercore ISI |
Robbie Marcus | JPMorgan |
Matt Taylor | UBS |
Jason Mills | Canaccord Genuity |
Raj Denhoy | Jefferies |
Matt Miksic | Credit Suisse |
Rick Wise | Stifel |
Chris Pasquale | Guggenheim |
Josh Jennings | Cowen & Company |
Pito Chickering | Deutsche Bank |
Jayson Bedford | Raymond James |
Adam Maeder | Piper Jaffray |
Greetings and welcome to the Edwards Lifesciences Third Quarter 2019 Results Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the conference over to our host, Mark Wilterding, Vice President of Investor Relations.